The global dental dam market size is calculated at USD 168.9 million in 2024, grew to USD 182.1 million in 2025, and is projected to reach around USD 350.2 million by 2034. The market is expanding at a CAGR of 7.74% between 2025 and 2034.
In May 2025, Dentsply Sirona leveraged strategic acquisitions to expand its dental dam product line and strengthen intellectual property in barrier materials. High Point University, located in High Point, North Carolina, and Dentsply Sirona, the biggest multifaceted manufacturer of professional dental products and technologies, are pleased to announce a special dental education partnership that will revolutionize educational opportunities. High Point University's innovative educational model and Dentsply Sirona's state-of-the-art products, technologies, and services are combined to provide future dental professionals with cutting-edge skills and practical experience in a modern dental practice curriculum.
Dental service organizations and multi-clinic chains are standardizing procurement, leading to greater bulk usage and inclusion of dental in clinical protocols.
Dental dams are increasingly being adapted for compatibility with digital workflows involving intraoral scanners, imaging systems, and treatment-planning software.
The U.S. stands as the principal driver of North America’s market, propelled by a robust healthcare infrastructure, high oral health awareness, and supportive reimbursement policies. Dental colleges and continuing education programs in the U.S. emphasize the use of dental dams, particularly in restorative and endodontic procedures, as a standard of care. Additionally, the region’s strong focus on patient safety and infection control has fostered widespread adoption among professionals, while favourable insurance coverage further encourages dentists to use higher-quality barrier tools like dental dams.
In Canada, while dental education is well-established with prominent institutions like the University of Toronto and UBC offering comprehensive programs, dental care is not generally included in publicly funded healthcare. According to a Statistics Canada survey, over one-third of Canadians reported not visiting a dentist in the past year, often due to cost or lack of insurance, highlighting access challenges. Though infection-control standards and clinical training likely encourage dental dam usage among professionals, reduced utilization is possible in underinsured or cost-sensitive populations.
R&D involves defining use cases (dental isolation or sexual health), selecting materials such as latex or polyurethane, prototyping, and performing bench tests for strength, leakage, and biocompatibility (ISO 10993).
Key Players: include manufacturers like Top Glove, dental suppliers such as Hu-Friedy, and accredited testing labs.
Clinical trial and approval steps begin with regulatory classification; in the U.S., the FDA requires a 510(k) pathway, supported by bench and biocompatibility data, usability studies, and clear instructions for use. In Europe, CE marking requires technical documentation reviewed by notified bodies. Organisations involved include the FDA, EU notified bodies, CROs, and regulatory consultants.
Patient support and service emphasize awareness, education, and safe usage through multilingual IFUs, demos, and outreach via NGOs like Planned Parenthood and CDC programs. Clinics, pharmacies, and e-commerce ensure accessibility, while customer service manages complaints and post-market surveillance.
In February 2025, Simon Campion, President and Chief Executive Officer of Dentsply Sirona, stated that the company had started the process of assessing strategic options for its Wellspect Healthcare division. As part of their recent transformation strategy, years, the Dentsply Sirona company made investments to fortify Wellspect’s base and set up the company for success in the future by giving top priority to product innovation and lucrative revenue growth, and capacity extension to satisfy projected increases in demand.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
